A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa

Agnieszka Piróg-Balcerzak; Anna Bażyńska; Katarzyna Biernacka; Joanna Brągoszewska; Lidia Popek; Barbara Remberk; Natalia Orlecka; Filip Rybakowski

eISSN: 2449-9315
ISSN: 1234-8279

Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Without publication fees

Open access

2/2020
vol. 36

Send email

Copy url:

abstract:

Original paper

A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa

Agnieszka M. Piróg-Balcerzak

¹

,

Anna K. Bażyńska

¹

,

Katarzyna Biernacka

¹

,

Joanna Brągoszewska

¹

,

Lidia Popek

²

,

Barbara Remberk

¹

,

Natalia Orlecka

¹

,

Filip Rybakowski

³

Institute of Psychiatry and Neurology in Warsaw
Mazovian Neuropsychiatric Center
Poznan University of Medical Sciences

Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (2), 95–106

Online publish date: 2021/12/06

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Piróg-Balcerzak AM, Bażyńska AK, Biernacka K, et al. A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2020;36(2):95-106.

APA

Piróg-Balcerzak, A. M., Bażyńska, A. K., Biernacka, K., Brągoszewska, J., Popek, L.,  & Remberk, B. et al. (2020). A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 36(2), 95-106.

Chicago

Piróg-Balcerzak, Agnieszka M, Anna K Bażyńska, Katarzyna Biernacka, Joanna Brągoszewska, Lidia Popek, Barbara Remberk,  and Natalia Orlecka et al. 2020. "A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii 36 (2): 95-106.

Harvard

Piróg-Balcerzak, A., Bażyńska, A., Biernacka, K., Brągoszewska, J., Popek, L., Remberk, B., Orlecka, N.,  and Rybakowski, F. (2020). A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 36(2), pp.95-106.

MLA

Piróg-Balcerzak, Agnieszka et al. "A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, vol. 36, no. 2, 2020, pp. 95-106.

Vancouver

Piróg-Balcerzak A, Bażyńska A, Biernacka K, Brągoszewska J, Popek L, Remberk B et al. A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2020;36(2):95-106.

Objective
Omega–3 polyunsaturated fatty acids (PUFAs) were tested in adolescent depression and in several neu rodevelopmental disorders with partial success. Anorexia nervosa (AN) is characterised by deficiencies in fatty food intake and frequent comorbidity, including depressive and cognitive symptoms. Thus supplementation with PUFAs may be beneficial in this group of patients. The aim of the study was to assess whether PUFAs as an add-on treatment is associated with better improvement of body mass index (BMI) and psychopathological symptoms than placebo in patients with AN.

Method
61 female adolescent inpatients with AN were randomly allocated to omega–3 PUFAs supplementation or placebo for 10 weeks. Patients also participated in the behavioural programme and eclectic psychotherapy (treatment as usual, TAU). At baseline and follow-up visits, patients’ BMI and psychopathology were assessed with Clinical Global Impression Scale (CGI), Patient Global Impression Scale (PGI), and Eating Attitude Test (EAT-26).

Results
After 10 weeks, both groups showed improve ment in all parameters. Improvement in CGI scores was observed greater in placebo vs. PUFA-s group (p = 0.015) while other differences were not statistically significant. Omega–3 PUFAs supplementation appears not to be ef fective as an add-on treatment in inpatient adolescent girls with anorexia nervosa.

Conclusions
The results should be analysed with cau tion due to small sample size and heterogeneity in TAU. As the TAU turned out to be highly effective, additional therapeutic effect of PUFA might not be visible. Never theless, that does not explain the tendency for better improvement in the placebo group.

keywords:

A randomized, double-blind, placebo-controlled study of polyunsaturated fatty acids efficacy in adolescents with anorexia nervosa

Agnieszka M. Piróg-Balcerzak 1 , Anna K. Bażyńska 1 , Katarzyna Biernacka 1 , Joanna Brągoszewska 1 , Lidia Popek 2 , Barbara Remberk 1 , Natalia Orlecka 1 , Filip Rybakowski 3

anorexia nervosa, omega–3 polyunsaturated fatty acids, adolescents

Agnieszka M. Piróg-Balcerzak

¹

,

Anna K. Bażyńska

¹

,

Katarzyna Biernacka

¹

,

Joanna Brągoszewska

¹

,

Lidia Popek

²

,

Barbara Remberk

¹

,

Natalia Orlecka

¹

,

Filip Rybakowski

³